Author

for NORTH Japan HCC study group

OpenAlex ID: A5157770971

Baseline Predictors, Prognostic Impact, and Risk Stratification of Early Progressive Disease on Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Study

2026 · Takuya Sho, Goki Suda, et al. · Liver Cancer

Works count: 1

Citation count:

H-index:

I10-index: